Clinical Trial Update: A Study of Guselkumab in Participants With Familial Adenomatous Polyposis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating guselkumab in participants with familial adenomatous polyposis has completed, reporting preliminary safety and dosing findings for th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Adenomatous Polyposis Coli | Phase 1 | Status: COMPLETED